Nonsteroidal Antiinflammatory Drugs, Acetaminophen, and Hypertension

Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials

(2011) Feng J He et al.   LANCET

Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies

(2011) Patricia McGettigan et al.   PLOS MEDICINE

Acetaminophen Increases Blood Pressure in Patients With Coronary Artery Disease

(2010) Isabella Sudano et al.   CIRCULATION

Blood Pressure Destabilization on Nonsteroidal Antiinflammatory Agents

(2010) William B. White et al.   CIRCULATION

The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials

(2010) Sébastien Czernichow et al.   JOURNAL OF HYPERTENSION

Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis

(2009) Matthew C. Becker et al.   AMERICAN HEART JOURNAL

Cardiovascular Risks of Nonsteroidal Antiinflammatory Drugs in Patients After Hospitalization for Serious Coronary Heart Disease

(2009) Wayne A. Ray et al.  

Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL study

(2009) Henry Krum et al.   JOURNAL OF HYPERTENSION

Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial

(2008) John A Baron et al.   LANCET

Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man

(2007) Burkhard Hinz et al.   FASEB JOURNAL